Sortilin may hold the key to combat pancreatic cancer more effectively. – Brinkwire

Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
“There is currently no good therapy for pancreatic cancer,” explained lead investigator Hubert Hondermarck, Ph.D., School of Biomedical…

Click here to view the original article.